New Cellebrite CEO Shiven Ramji.

Cellebrite to lay off dozens of employees amid management shake-up

The Nasdaq-listed Israeli cyber intelligence company employs approximately 1,200 people worldwide and is reorganizing its operations following a series of executive changes and a broader strategic shift.

Cellebrite, the Nasdaq-listed cyber and digital intelligence company, is expected to announce a round of layoffs today (Monday), affecting dozens of its approximately 1,200 employees worldwide. The job cuts are part of a reorganization aimed at aligning the company's structure with its business objectives.
The move comes amid a period of significant change in Cellebrite's management and business strategy. In August, Shiven Ramji was appointed CEO, succeeding Thomas Hogan, who had held the position since August 2025. Ramji had joined the company in May 2026 as President of Products and Technology. Meanwhile, in July, Ronen Armon, who had led the Products and Technology organization for nearly six years, stepped down. In November, the company also announced the appointment of Rogerio Rizzi as executive vice president of Corporate Strategy and Development.
1 View gallery
שיבן רמג'י מנכ"ל סלברייט
שיבן רמג'י מנכ"ל סלברייט
New Cellebrite CEO Shiven Ramji.
(Photos: Cellebreite, Shutterstock)
Cellebrite is also undergoing a broader business transformation. In September, the company announced plans to relocate its place of incorporation from Israel to the United States, a move intended to strengthen its position in the American market and broaden its investor base. The company said its operations in Israel are expected to continue as usual.
The layoffs come just days after Cellebrite released its third-quarter 2026 results. The company reported revenue of $149 million, up 18% from the same quarter last year. Subscription revenue totaled $134.9 million, an increase of 20%. Net income reached $26.7 million, compared with $20.2 million in the corresponding quarter last year. Adjusted non-GAAP net income stood at $45.6 million, while adjusted EBITDA reached $53.6 million, representing a margin of 36%.
Cellebrite ended the quarter with annual recurring revenue (ARR) of $528.5 million, up 20% year over year. Following the results, the company raised its full-year 2026 adjusted EBITDA guidance to between $163 million and $166 million. It expects annual revenue of between $553 million and $558 million.